A federal district judge granted a temporary restraining order Monday, blocking the Trump administration from making drastic ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Attorneys general from 22 states had filed a lawsuit seeking to block the policy that would dramatically change NIH's grant-making by limiting how much it will disburse for overhead costs.

In recent days there have been reports of Executive Orders and federal agency notices that have far-reaching implications for ...

Applications for a prestigious National Institutes of Health grant program that supports Ph.D. students from marginalized backgrounds are abruptly being pulled from consideration during grant ...

A recently announced move by the National Institutes of Health to reduce federal grant funding for indirect costs related to biomedical research threatens to put a stop to some programs and could ...

Industry leaders also questioned whether the move was legal, pointing to existing law governing NIH funding. “This is a surefire way to cripple lifesaving research and innovation,” Matt Owens ...

NIH Acting Director Matthew Memoli, MD, announced the cuts on Friday afternoon. The announcement noted that while indirect cost funding is usually negotiated individually with each institution ...

The NIH, the largest funder of biomedical research in the U.S., will limit funding for indirect costs to 15%. Indirect costs cover expenses like building maintenance and administrative salaries.

The National Institutes of Health abruptly released new guidelines that will lead to reduced research funding at UVA and ...

In the announcement, NIH said that of roughly $35 billion spent funding 300,000 researchers nationwide in 2023, $9 billion went to indirect costs. The move to a lower indirect cost rate ...